Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, et al. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 356:125-134.
Goodman VL, Rock EP, Dagher R, Ramchandani RP, Abraham S, Gobburu JV, et al. (2007) Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma. Clin Cancer Res. 13:1367-1373.